CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers

University of Hawaii

Status: Begins enrollment in 7 months

Conditions: Oncology; Cancer

Treatments: Other: Provider Education Intervention; Other: Patient Education Intervention

Study type: Interventional

Funder types: Other; Other U.S. Federal agency

Identifiers

NCT06237816

Okado-2023-2

Details and patient eligibility

About

The overall goal of the project is to pilot test CTNow, a multilevel intervention designed to facilitate access and referrals to cancer clinical trials in rural areas through patient and provider education and teleconference resources.

Enrollment: 35 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients must have been diagnosed with any cancer.
• Patients who have received treatment, are receiving cancer treatment at the time of enrollment, or estimated to start treatment within 90 days.
• Patients must be ≥ 18 years of age. Patients must be able to read, write, and speak English. Study materials and telephone calls are only available in English.

Patients must be residents of Hawaii, Kauai, or Maui counties.

Exclusion criteria

• Patients must not have previously participated in a cancer clinical trial. Those who have participated in a cancer clinical trial are not eligible for the study.

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

35 participants in 2 patient groups

Patient Education Intervention

Experimental group

Description:

A multimedia educational series is designed to provide patient education on cancer clinical trials. The following topics are addressed: * What is a clinical trial? * Types of clinical trials. * Phases of clinical trials. * Benefits and drawbacks. * Costs. * FAQs. This section covers common myths and clarifies these myths using a Q\&A format. * How to join a clinical trial. Information about eligibility and informed consent. * Clinical trial stories. Testimonies from oncology providers and patients. Each module is approximately 2-5 minutes, and they can be reviewed in the order/schedule preferred by the patient. The overall program is 30 minutes to view including the videos. The tablet provided to patients provides additional benefits for participation.

Treatment:

Other: Patient Education Intervention

Provider Education Intervention

Experimental group

Description:

The provider education intervention will consist of 3 provider informational sessions conducted individually. These individual provider sessions will be conducted by teleconference by the research team and scheduled according to provider's availability. Provider workshops are designed to provide both a background on clinical trial infrastructure in Hawaii and resources for additional information. The content of these sessions includes: * An overview of clinical trials infrastructure in Hawaii. * Available trials in Hawaii. At each informational session, the research team will review available trials and any new/upcoming trials with the provider. * An overview of how to get involved in clinical trials. As experience and background re: clinical trials may vary across providers, the content of these informational sessions will be tailored to each provider. Following the initial session, 2 additional meetings will be scheduled in 4-6 months as follow-up sessions.

Treatment:

Other: Provider Education Intervention